Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8126 items · filings · clear filters
- 8-K - AUDDIA INC. (0001554818) (Filer)
Auddia Inc. filed a Form 8-K on October 6, 2026, reporting a submission of matters to a vote of security holders (Item 5.07), other events (Item 8.01), and accompanying financial statements and exhibits (Item 9.01).
- 8-K - RTB Digital, Inc. (0001419275) (Filer)
RTB Digital, Inc. filed a Form 8-K on October 6, 2026 reporting the departure, election or appointment of certain directors and officers and related compensatory arrangements, and providing its financial statements and accompanying exhibits.
- 8-K - Option Care Health, Inc. (0001014739) (Filer)
Option Care Health, Inc. filed a Form 8-K on October 6 2026 reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Onar Holding Corp (0001682265) (Filer)
Onar Holding Corp filed a Form 8-K reporting a material definitive agreement, changes to its board and officers, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - HUBSPOT INC (0001404655) (Filer)
HubSpot Inc. filed a Form 8-K on October 6 2026, reporting results of operations and financial condition, costs associated with exit or disposal activities, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - MAIA Biotechnology, Inc. (0001878313) (Filer)
MAIA Biotechnology, Inc. filed a Form 8-K on October 6, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - STRYKER CORP (0000310764) (Filer)
Stryker Corp filed a Form 8-K on Oct. 6, 2026, reporting director/officer departures and appointments, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - INTERNATIONAL BANCSHARES CORP (0000315709) (Filer)
International Bancshares Corp filed a Form 8-K on Oct 6, 2026, reporting a notice of delisting or failure to meet a continued listing rule and a transfer of listing, along with Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - ArriVent BioPharma, Inc. (0001868279) (Filer)
ArriVent BioPharma, Inc. filed a Form 8-K on October 6, 2026 (Accession No. 0001104659-26-113898) containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - PDS Biotechnology Corp (0001472091) (Filer)
PDS Biotechnology Corp filed a Form 8-K on October 6, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - NETLIST INC (0001282631) (Filer)
Netlist Inc. filed an 8-K on October 6, 2026 reporting entry into a material definitive agreement, unregistered sales of equity securities, other events, and the inclusion of financial statements and related exhibits.
- 8-K - MCKESSON CORP (0000927653) (Filer)
McKesson Corp filed a Form 8-K on October 6, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Lamb Weston Holdings, Inc. (0001679273) (Filer)
Lamb Weston Holdings filed a Form 8-K on October 6, 2026, including Item 2.02 reporting its results of operations and financial condition and Item 9.01 containing its financial statements and related exhibits.
- 8-K - FULLER H B CO (0000039368) (Filer)
Fuller H B Co filed a Form 8-K on October 6, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Portillo's Inc. (0001871509) (Filer)
Portillo's Inc. filed a Form 8-K reporting the departure of certain directors or officers, the election or appointment of new directors/officers, and disclosed compensatory arrangements for the appointed officers.
- 8-K - B&G Foods, Inc. (0001278027) (Filer)
B&G Foods, Inc. filed a Form 8-K with the SEC on October 6 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - 1606 CORP. (0001877461) (Filer)
1606 Corp. filed a Form 8-K on October 6, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Telomir Pharmaceuticals, Inc. (0001971532) (Filer)
Telomir Pharmaceuticals filed an 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Boost Run Inc. (0002090646) (Filer)
Boost Run Inc. filed a Form 8-K on October 6, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.
- 8-K - SideChannel, Inc. (0001022505) (Filer)
SideChannel, Inc. filed a Form 8-K on Oct 6, 2026, reporting amendments to its articles of incorporation or bylaws and a change in fiscal year, and providing financial statements and related exhibits.
- 8-K - Entera Bio Ltd. (0001638097) (Filer)
Entera Bio Ltd. filed a Form 8-K on October 6, 2026 reporting director and officer departures, elections, appointments and related compensation arrangements, providing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - OFS Capital Corp (0001487918) (Filer)
OFS Capital Corp filed a Form 8-K with the SEC on October 6, 2026, reporting under Item 8.01 (Other Events).
- 8-K - Evolution Metals & Technologies Corp. (0001866226) (Filer)
Evolution Metals & Technologies Corp. filed a Form 8-K on October 6, 2026, containing a Regulation FD disclosure and the company's financial statements and related exhibits.
- 8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer)
Regeneron filed a Form 8-K on October 6, 2026, reporting entry into a material definitive agreement, presenting its results of operations and financial condition, and disclosing other events.
- 8-K - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Filer)
60 Degrees Pharmaceuticals, Inc. filed a Form 8-K on October 6, 2026, including a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Valion Bio, Inc. (0001787740) (Filer)
Valion Bio, Inc. filed a Form 8-K on October 6, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001437749-26-032107.
- 8-K - Kairos Pharma, LTD. (0001962011) (Filer)
Kairos Pharma, Ltd. filed a Form 8-K on October 6, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001493152-26-045844.
- 8-K - Professional Diversity Network, Inc. (0001546296) (Filer)
Professional Diversity Network, Inc. filed a Form 8-K on October 6, 2026, reporting a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Indivior Pharmaceuticals, Inc. (0001625297) (Filer)
Indivior Pharmaceuticals, Inc. filed a Form 8-K with the SEC on October 6, 2026, reporting an Item 8.01 Other Events disclosure (Accession No. 0001104659-26-113883).
- 8-K - Beeline Holdings, Inc. (0001534708) (Filer)
Beeline Holdings, Inc. filed a Form 8-K on October 6, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).